您的当前位置:首页 > 行业数据 > BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率
图片属性
图片格式:PNG 图片大小:486KB 图片尺寸:2346*1319
同报告图片
 / 4
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率_第1页
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
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率_第2页
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率_第3页
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率_第4页
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
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率_第5页
所属报告: 医药健康行业深度研究:从第一三共ADC药物商业成功看国内ADC投资映射-250308(20页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠